NCT00093353 2026-04-14
N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
Phase 1 Completed
Clinical Trials
11 trialsNCT04038619 2026-03-20
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT07426822 2026-02-24
SAFE-CAP
Yale University
Phase 2 Not yet recruiting
NCT07338643 2026-01-14
The Auxiliary Effect of Artificial Intelligence in the Detection of Precancerous Lesions in Proximal Colon Cancer
Hebei Medical University Fourth Hospital
Not yet recruiting
NCT07264985 2025-12-04
Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib
Hubei Cancer Hospital
Not yet recruiting
NCT06801067 2025-12-02
A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT06206707 2025-11-17
Immunobiome
University of Aarhus
Phase NA Recruiting
NCT03767257 2025-10-21
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT03499808 2025-09-09
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
SWOG Cancer Research Network
Phase 2 Completed
NCT06892093 2025-09-08
Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase NA Recruiting
NCT06960122 2025-05-07
FMT-TP
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Not yet recruiting